Latest Industry News & Trends

Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.

Generics News

11/19/2025
GenericsIndustryNewsletterPharma
Mallinckrodt Spins Off Generics Business, Rebrands as Keenova
Mallinckrodt Spins Off Generics Business,  Rebrands as Keenova

Drugmaker Mallinckrodt announced Nov. 10 that it had completed the planned spinoff of its Par Health generic pharmaceuticals and sterile injectables businesses and had rebranded as Keenova Therapeu...

10/23/2025
BiosimilarsCataractChinaCornealDealsDiagnosticDry EyeEuropeGene TherapyGenericsGlaucomaIndiaIndustryMIGSNewsletterPharmaPresbyopiaRegulationRetinaSurgical
October 2025 Ophthalmic News Briefs
October 2025 Ophthalmic News Briefs

Biotech Healthcare announced Sept. 23 that it had launched the Optiflex Xtense Comfort Plus extended-depth-of-focus (EDOF) intraocular lens at the ESCRS 2025 congress in Copenhagen, Denmark. Biotec...

10/10/2025
BreakingGenericsPharmaRegulation
Generic Drugmakers with US Sources Now Eligible for FDA Priority Review
Generic Drugmakers with US Sources Now Eligible for FDA Priority Review

The US FDA reported Oct. 3 that a new pilot program would speed the approval process for some generic drugmakers: They would be eligible for priority review if they conducted any required bioequiva...

8/23/2024
BreakingGenericsIndiaRegulation
US FDA Grants Tentative Approval to Generic Brimonidine Tartrate Ophthalmic Solution (Lumify) from Lupin
US FDA Grants Tentative Approval to Generic Brimonidine Tartrate Ophthalmic Solution (Lumify) from Lupin

Indian drugmaker Lupin announced Aug. 14 that it had received tentative approval from the US FDA for its abbreviated new drug application for brimonidine tartrate ophthalmic solution 0.025%, a gene...

Want to Read the Full Article?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more